Here at Source Advisors, we know our SME clients are innovating every day, resulting in significant rewards under the R&D tax relief scheme. Unfortunately we don’t see those same companies capturing and commercialising that innovation with an IP strategy or through a patent. The barriers could be:
Projected for the tax year 2021-22
Projected for the tax year 2021-22
Source Advisors can help your business optimise the value of your R&D through tax relief schemes, including Research and Development Expenditure Credit (RDEC), the new merged scheme and the Enhanced R&D Intensive Support (ERIS) scheme.
R&D is a good indicator of a company’s potential for a Patent Box claim – it’s a conversation that every R&D tax relief claimant should be having.
There has been a lot of angst in our industry about the rate at which HMRC has been opening enquiries. For Source Advisors’ clients who
Earlier this month, HMRC released draft guidance around two key restrictions coming into force as part of the new merged R&D tax relief scheme scheduled
At the end of November 2023, we held our second roundtable discussion. Following the success of our first event in April 2023, it is important
